Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Christoph

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Clinical Lung Cancer|September 13, 2018
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaFiliz Oezkan, Thomas Herold, Kaid Darwiche, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Cancers|April 30, 2021
Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in ImmunogenicityLuka Brcic, Alexander Mathilakathu, Robert F H Walter, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Journal of Psychiatric Research|September 29, 2012
Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophreniaIgor Nenadic, Raka Maitra, Sigrid Scherpiet, et al.
Oncotarget|June 2, 2018
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapyFabian D Mairinger, Jan Schmeller, Sabrina Borchert, et al.
BMC Cancer|February 1, 2019
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitroSabrina Borchert, Michael Wessolly, Jan Schmeller, et al.
Oncology Research and Treatment|May 26, 2025
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous ThromboembolismMarianne Sinn, Anja Lohneis, Omar Mohamed, et al.
Journal of Oncology|August 17, 2018
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53Robert F H Walter, Robert Werner, Michael Wessolly, et al.
Cancers|June 2, 2021
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)Philip Zeuschner, Sebastian Hölters, Michael Stöckle, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Lung Cancer|September 13, 2018
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaFiliz Oezkan, Thomas Herold, Kaid Darwiche, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Cancers|April 30, 2021
Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in ImmunogenicityLuka Brcic, Alexander Mathilakathu, Robert F H Walter, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Journal of Psychiatric Research|September 29, 2012
Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophreniaIgor Nenadic, Raka Maitra, Sigrid Scherpiet, et al.
Oncotarget|June 2, 2018
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapyFabian D Mairinger, Jan Schmeller, Sabrina Borchert, et al.
BMC Cancer|February 1, 2019
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitroSabrina Borchert, Michael Wessolly, Jan Schmeller, et al.
Oncology Research and Treatment|May 26, 2025
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous ThromboembolismMarianne Sinn, Anja Lohneis, Omar Mohamed, et al.
Journal of Oncology|August 17, 2018
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53Robert F H Walter, Robert Werner, Michael Wessolly, et al.
Cancers|June 2, 2021
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study)Philip Zeuschner, Sebastian Hölters, Michael Stöckle, et al.
Pageof 11